Jill M. Wagner

2.0k total citations
24 papers, 1.5k citations indexed

About

Jill M. Wagner is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Jill M. Wagner has authored 24 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Rheumatology. Recurrent topics in Jill M. Wagner's work include DNA Repair Mechanisms (10 papers), Eosinophilic Disorders and Syndromes (7 papers) and PARP inhibition in cancer therapy (7 papers). Jill M. Wagner is often cited by papers focused on DNA Repair Mechanisms (10 papers), Eosinophilic Disorders and Syndromes (7 papers) and PARP inhibition in cancer therapy (7 papers). Jill M. Wagner collaborates with scholars based in United States, Denmark and Sweden. Jill M. Wagner's co-authors include Larry M. Karnitz, Masahiko Kobayashi, Ken-ichi Yamamoto, Sinny Delacroix, Gerald J. Gleich, Scott H. Kaufmann, Gail M. Kephart, Catherine J. Huntoon, Amelia M. Huehls and Motoki Bonno and has published in prestigious journals such as Journal of Biological Chemistry, Genes & Development and PLoS ONE.

In The Last Decade

Jill M. Wagner

24 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jill M. Wagner United States 18 915 494 207 200 186 24 1.5k
Norihito Kawasaki Japan 27 846 0.9× 280 0.6× 131 0.6× 231 1.2× 93 0.5× 60 1.8k
Mahefatiana Andrianifahanana United States 17 777 0.8× 465 0.9× 71 0.3× 267 1.3× 30 0.2× 22 1.4k
Sanjana Mehrotra India 16 678 0.7× 776 1.6× 55 0.3× 98 0.5× 55 0.3× 60 1.8k
Takashi Tanaka Japan 10 606 0.7× 679 1.4× 303 1.5× 163 0.8× 87 0.5× 11 2.1k
Luc Desnoyers United States 16 1.1k 1.2× 212 0.4× 35 0.2× 119 0.6× 142 0.8× 29 1.7k
AM Gianni Italy 22 738 0.8× 584 1.2× 158 0.8× 68 0.3× 35 0.2× 45 2.0k
V. Patel United States 20 798 0.9× 601 1.2× 84 0.4× 90 0.5× 20 0.1× 33 1.5k
Jan E. Ehlert Germany 14 587 0.6× 970 2.0× 94 0.5× 133 0.7× 49 0.3× 27 2.1k
Martina Vockerodt Germany 21 643 0.7× 1.0k 2.1× 112 0.5× 51 0.3× 87 0.5× 38 2.2k
Benoit Pasquier France 12 648 0.7× 319 0.6× 106 0.5× 62 0.3× 45 0.2× 13 2.2k

Countries citing papers authored by Jill M. Wagner

Since Specialization
Citations

This map shows the geographic impact of Jill M. Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill M. Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill M. Wagner more than expected).

Fields of papers citing papers by Jill M. Wagner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill M. Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill M. Wagner. The network helps show where Jill M. Wagner may publish in the future.

Co-authorship network of co-authors of Jill M. Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Jill M. Wagner. A scholar is included among the top collaborators of Jill M. Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill M. Wagner. Jill M. Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hendrickson, Andrea E. Wahner, Daniel W. Visscher, Xiaonan Hou, et al.. (2021). CHFR and Paclitaxel Sensitivity of Ovarian Cancer. Cancers. 13(23). 6043–6043. 2 indexed citations
2.
Huehls, Amelia M., Catherine J. Huntoon, Poorval Joshi, et al.. (2015). Genomically Incorporated 5-Fluorouracil that Escapes UNG-Initiated Base Excision Repair Blocks DNA Replication and Activates Homologous Recombination. Molecular Pharmacology. 89(1). 53–62. 42 indexed citations
3.
Huehls, Amelia M., Jill M. Wagner, Catherine J. Huntoon, & Larry M. Karnitz. (2012). Identification of DNA Repair Pathways That Affect the Survival of Ovarian Cancer Cells Treated with a Poly(ADP-Ribose) Polymerase Inhibitor in a Novel Drug Combination. Molecular Pharmacology. 82(4). 767–776. 31 indexed citations
4.
Huehls, Amelia M., Jill M. Wagner, Catherine J. Huntoon, et al.. (2011). Poly(ADP-Ribose) Polymerase Inhibition Synergizes with 5-Fluorodeoxyuridine but not 5-Fluorouracil in Ovarian Cancer Cells. Cancer Research. 71(14). 4944–4954. 42 indexed citations
5.
Wagner, Jill M. & Larry M. Karnitz. (2009). Cisplatin-Induced DNA Damage Activates Replication Checkpoint Signaling Components that Differentially Affect Tumor Cell Survival. Molecular Pharmacology. 76(1). 208–214. 104 indexed citations
6.
Gálvez‐Peralta, Marina, Nga T. Dai, David A. Loegering, et al.. (2008). Overcoming S-Phase Checkpoint-Mediated Resistance: Sequence-Dependent Synergy of Gemcitabine and 7-Ethyl-10-hydroxycamptothecin (SN-38) in Human Carcinoma Cell Lines. Molecular Pharmacology. 74(3). 724–735. 9 indexed citations
7.
Delacroix, Sinny, Jill M. Wagner, Masahiko Kobayashi, Ken-ichi Yamamoto, & Larry M. Karnitz. (2007). The Rad9–Hus1–Rad1 (9–1–1) clamp activates checkpoint signaling via TopBP1. Genes & Development. 21(12). 1472–1477. 364 indexed citations
8.
Matthews, David J., Jason Chen, Lester M. Bornheim, et al.. (2007). Pharmacological Abrogation of S-Phase Checkpoint Enhances the Anti-Tumor Activity of Gemcitabine In Vivo. Cell Cycle. 6(1). 104–110. 109 indexed citations
9.
Karnitz, Larry M., Karen S. Flatten, Jill M. Wagner, et al.. (2005). Gemcitabine-Induced Activation of Checkpoint Signaling Pathways That Affect Tumor Cell Survival. Molecular Pharmacology. 68(6). 1636–1644. 108 indexed citations
10.
Arlander, Sonnet J.H., Sara J. Felts, Jill M. Wagner, et al.. (2005). Chaperoning Checkpoint Kinase 1 (Chk1), an Hsp90 Client, with Purified Chaperones. Journal of Biological Chemistry. 281(5). 2989–2998. 70 indexed citations
11.
Christiansen, Michael, Claus Oxvig, Jill M. Wagner, et al.. (1999). The proform of eosinophil major basic protein: a new maternal serum marker for Down syndrome. Prenatal Diagnosis. 19(10). 905–910. 24 indexed citations
12.
Sur, Sanjiv, Dohn G. Glitz, Hirohito Kita, et al.. (1999). Localization of Eosinophil–Derived Neurotoxin and Eosinophil Cationic Protein in Neutrophilic Leukocytes. International Archives of Allergy and Immunology. 118(2-4). 255–258. 21 indexed citations
13.
Plager, Douglas A., David A. Loegering, Deborah A. Weiler, et al.. (1999). A Novel and Highly Divergent Homolog of Human Eosinophil Granule Major Basic Protein. Journal of Biological Chemistry. 274(20). 14464–14473. 59 indexed citations
14.
Rhoton-Vlasak, Alice, Jill M. Wagner, Joanne L. Rutgers, et al.. (1998). Placental site trophoblastic tumor: Human placental lactogen and pregnancy-associated major basic protein as immunohistologic markers. Human Pathology. 29(3). 280–288. 19 indexed citations
15.
Katô, Masahiko, Gail M. Kephart, Nicholas J. Talley, et al.. (1998). Eosinophil infiltration and degranulation in normal human tissue. The Anatomical Record. 252(3). 418–425. 162 indexed citations
16.
Oxvig, Claus, Jesper Haaning, Lene Juel Kristensen, et al.. (1995). Identification of Angiotensinogen and Complement C3dg as Novel Proteins Binding the Proform of Eosinophil Major Basic Protein in Human Pregnancy Serum and Plasma. Journal of Biological Chemistry. 270(23). 13645–13651. 62 indexed citations
17.
Minnicozzi, Michael, Walter N. Durán, Donghyun Kim, et al.. (1995). Tissue eosinophilia induced by recombinant human interleukin‐5 in the hamster cheek pouch membrane. Mediators of Inflammation. 4(5). 331–338. 1 indexed citations
18.
Sur, Sanjiv, Gerald J. Gleich, Kenneth P. Offord, et al.. (1995). Allergen challenge in asthma: association of eosinophils and lymphocytes with interleukin‐5. Allergy. 50(11). 891–898. 17 indexed citations
19.
Wagner, Jill M., Kathleen R. Bartemes, Sandra L. Dunnette, et al.. (1993). Analysis of pregnancy-associated major basic protein levels throughout gestation. Placenta. 14(6). 671–681. 43 indexed citations
20.
Wasmoen, Terri, Jill M. Wagner, Kathleen R. Bartemes, & Gerald J. Gleich. (1992). Plasma levels of eosinophil granule major basic protein in pregnant cynomolgus monkeys. Placenta. 13(3). 265–272. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Norihito Kawasaki Breakdown of academic impact, for papers by Mahefatiana Andrianifahanana Breakdown of academic impact, for papers by Sanjana Mehrotra Breakdown of academic impact, for papers by Takashi Tanaka Breakdown of academic impact, for papers by Luc Desnoyers Breakdown of academic impact, for papers by AM Gianni Breakdown of academic impact, for papers by V. Patel Breakdown of academic impact, for papers by Jan E. Ehlert Breakdown of academic impact, for papers by Martina Vockerodt Breakdown of academic impact, for papers by Benoit Pasquier
Rankless by CCL
2026